Skye Bioscience Inc (SKYE)

[Closewatcher]

I'd say this news is pretty good. Any time they are presenting data for the superiority of their compounds is a good sign and means the lulls of time are being put to good use.

There's really only two catalysts in the near-term that you (we) are looking for, and thats the close of financing and the filing of the 502(B) for CINV. I think at this point Murphy is trying to be as close to accurate as possible with timelines, in which case that was "3Q or 4Q" for the IND. We're halfway through 3Q, so realistically October is where we should be antsy for the IND.